NCT00265772 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Status UNKNOWN Phase PHASE4
NCT00257699 Study of Antibiotics in the Treatment of Colonic Crohn's Disease Status TERMINATED Phase PHASE2
NCT00252369 Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment. Status TERMINATED Phase NA
NCT00250198 The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease Status COMPLETED Phase PHASE2
NCT00245505 The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" Status TERMINATED Phase PHASE3
NCT00234741 Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT00225810 A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease Status COMPLETED Phase PHASE4
NCT00224562 The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Status UNKNOWN Phase N/A
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT00221026 Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease Status COMPLETED Phase PHASE2
NCT00215020 Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00178438 Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease Status WITHDRAWN Phase PHASE1/PHASE2
NCT00175292 A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. Status COMPLETED Phase PHASE3
NCT00167882 The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels Status COMPLETED Phase PHASE4
NCT00160706 A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease Status COMPLETED Phase PHASE3